CD93 and neoplasm: Furthermore, both the percentages and numbers of B220+CD93+ immature B cells were increased, whereas B220+CD93-CD21intCD23+ follicular B cells were decreased in tumor-bearing IDO deficient mice compared with naïve IDO deficient mice (Supplementary Figures 10A, B).